MA MD FRCS
Research Fellow, Clinical Trial Service Unit, University of Oxford
- Consultant Vascular Surgeon, Cheltenham General Hospital
Richard studied medicine at Cambridge University and The Royal London Hospital, graduating in 1994. Following surgical training in London, Oxford, and the South West of England, he was appointed to his consultant post in 2009.
Richard combines a busy vascular and endovascular practice in Gloucestershire (UK) with research work at the Clinical Trial Service Unit (CTSU).
His academic interests centre around the design, conduct and analyses of large randomised trials and include the use of lipid-lowering and anti-thrombotic therapy to reduce vascular risk (HPS, SEARCH, HPS 2-THRIVE, HPS 3-REVEAL Collaborator). He coordinates the long-term follow-up of HPS and SEARCH, using data linkage to electronic health records.
He is also Co-PI of ACST-2, a large international randomised trial comparing carotid endarterectomy versus carotid artery stenting in asymptomatic carotid artery disease. This trial aims to randomise 3600 patients during the 2010s, yielding uniquely reliable evidence about the short term hazards and long-term durability of stenting and surgery for stroke prevention.
Response to the Comment on "Meta-analysis of Effect of Volume (Hospital and Operator) on Carotid Revascularization Outcomes".
Poorthuis MHF. et al, (2021), Annals of surgery, 274
Joint Associations Between Body Mass Index and Waist Circumference With Atrial Fibrillation in Men and Women.
Poorthuis MHF. et al, (2021), J Am Heart Assoc
Risk of Stroke before Revascularisation in Patients with Symptomatic Carotid Stenosis: A Pooled Analysis of Randomised Controlled Trials.
Fisch U. et al, (2021), Eur J Vasc Endovasc Surg
Development and Internal Validation of a Risk Score to Detect Asymptomatic Carotid Stenosis.
Poorthuis MHF. et al, (2021), Eur J Vasc Endovasc Surg, 61, 365 - 373
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
RECOVERY Collaborative Group None., (2021), Lancet, 397, 605 - 612